An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)
Clinical trial NCT00090285 · COMPLETED
Trial details
- NCT number
- NCT00090285
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-03
- Primary completion
- 2009-07-31
- Enrollment
- 4065
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.